Issue identification paper : drug-device combination products (DDCPS) : draft for consultation.: H164-377/2021E-PDF
"This paper is intended to identify the key challenges associated with Health Canada’s oversight of drug-device combination products (DDCPs) as per Health Canada’s Policy on Drug/Medical Device Combination Products (the Policy). DDCPs are health products that combine drugs and medical devices as a single entity. For the purposes of this paper, a drug is considered to be a pharmaceutical, radiopharmaceutical, natural health product (NHP), biologic, cell, tissue, organ, gene therapy, or human blood and its components"--Objective, page 3.
Permanent link to this Catalogue record:
publications.gc.ca/pub?id=9.940313&sl=0
| Department/Agency | Canada. Health Canada, issuing body. |
|---|---|
| Title | Issue identification paper : drug-device combination products (DDCPS) : draft for consultation. |
| Variant title | Drug-device combination products (DDCPS) |
| Publication type | Monograph |
| Language | [English] |
| Other language editions | [French] |
| Format | Electronic |
| Electronic document | |
| Note(s) | Issued also in French under title: Documentation de détermination des enjeux : produits mixtes médicaments-instruments médicaux : ébauche aux fins de consultation. "Draft date: 2021/05/10." Includes bibliographical references (page 13). |
| Publishing information | [Ottawa] : Health Canada = Santé Canada, May 10, 2021. |
| Description | 1 online resource (13 pages) |
| Catalogue number |
|
| Subject terms | Medical instruments and apparatus -- Government policy -- Canada. Drugs -- Government policy -- Canada. |